jCyte
Dr. Yang has worked as a physician-scientist in ophthalmology for more than 16 years, beginning her career at the Peking University Eye Center. Later, she began studying regenerative medicine at the University of Copenhagen, developing new ways to isolate and grow retinal progenitor cells; and served as an adjunct professor in the Department of Opthalmology at the University of California, Irvine from 2013 to 2022.
She has developed pivotal techniques to advance stem cell therapies and is also exploring other clinical applications for retinal progenitor cells, such as using them to treat glaucoma and other optic nerve diseases.
This person is not in any offices
jCyte
1 followers
jCyte is a clinical-stage company focused on the application of progenitor cell-based technology in retinal diseases. The Company's allogeneic product candidate, jCell, is delivered by simple intravitreal injection without the need for surgery or immune suppression.